
David S. Romeo
Examiner (ID: 10447, Phone: (571)272-0890 , Office: P/1647 )
| Most Active Art Unit | 1647 |
| Art Unit(s) | 1647, 1801, 1643, 1646 |
| Total Applications | 1149 |
| Issued Applications | 531 |
| Pending Applications | 95 |
| Abandoned Applications | 523 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6534663
[patent_doc_number] => 20100204104
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-12
[patent_title] => 'FUSION PROTEINS CONTAINING TWO TGF-BETA BINDING DOMAINS OF TGF-BETA TYPE II RECEPTOR'
[patent_app_type] => utility
[patent_app_number] => 12/663638
[patent_app_country] => US
[patent_app_date] => 2008-12-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 12154
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0204/20100204104.pdf
[firstpage_image] =>[orig_patent_app_number] => 12663638
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/663638 | FUSION PROTEINS CONTAINING TWO TGF-BETA BINDING DOMAINS OF TGF-BETA TYPE II RECEPTOR | Dec 23, 2008 | Abandoned |
Array
(
[id] => 5434964
[patent_doc_number] => 20090169550
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-02
[patent_title] => 'THERAPY OF RITUXIMAB-REFRACTORY RHEUMATOID ARTHRITIS PATIENTS'
[patent_app_type] => utility
[patent_app_number] => 12/339476
[patent_app_country] => US
[patent_app_date] => 2008-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36426
[patent_no_of_claims] => 71
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0169/20090169550.pdf
[firstpage_image] =>[orig_patent_app_number] => 12339476
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/339476 | THERAPY OF RITUXIMAB-REFRACTORY RHEUMATOID ARTHRITIS PATIENTS | Dec 18, 2008 | Abandoned |
Array
(
[id] => 6614680
[patent_doc_number] => 20100310515
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-09
[patent_title] => 'Latency Associated Protein Construct With Aggrecanase Sensitive Cleavage Site'
[patent_app_type] => utility
[patent_app_number] => 12/808383
[patent_app_country] => US
[patent_app_date] => 2008-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 7838
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0310/20100310515.pdf
[firstpage_image] =>[orig_patent_app_number] => 12808383
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/808383 | Latency associated protein construct with aggrecanase sensitive cleavage site | Dec 16, 2008 | Issued |
Array
(
[id] => 8653051
[patent_doc_number] => 08372799
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-02-12
[patent_title] => 'Reverse protein'
[patent_app_type] => utility
[patent_app_number] => 12/747741
[patent_app_country] => US
[patent_app_date] => 2008-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 9
[patent_no_of_words] => 5709
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12747741
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/747741 | Reverse protein | Dec 11, 2008 | Issued |
Array
(
[id] => 6102574
[patent_doc_number] => 20110166067
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-07
[patent_title] => 'METHODS FOR INHIBITION OF SCARRING'
[patent_app_type] => utility
[patent_app_number] => 13/003760
[patent_app_country] => US
[patent_app_date] => 2008-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 14515
[patent_no_of_claims] => 71
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20110166067.pdf
[firstpage_image] =>[orig_patent_app_number] => 13003760
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/003760 | METHODS FOR INHIBITION OF SCARRING | Dec 10, 2008 | Abandoned |
Array
(
[id] => 5391198
[patent_doc_number] => 20090208511
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-20
[patent_title] => 'Novel method for identifying diabetic patients at increased risk for pathological complications'
[patent_app_type] => utility
[patent_app_number] => 12/315526
[patent_app_country] => US
[patent_app_date] => 2008-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 26734
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0208/20090208511.pdf
[firstpage_image] =>[orig_patent_app_number] => 12315526
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/315526 | Method for identifying diabetic patients at increased risk for pathological complications | Dec 3, 2008 | Issued |
Array
(
[id] => 6095180
[patent_doc_number] => 20110002880
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-06
[patent_title] => 'Material For Wound Healing and Skin Reconstruction'
[patent_app_type] => utility
[patent_app_number] => 12/746520
[patent_app_country] => US
[patent_app_date] => 2008-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 5750
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0002/20110002880.pdf
[firstpage_image] =>[orig_patent_app_number] => 12746520
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/746520 | Material For Wound Healing and Skin Reconstruction | Dec 3, 2008 | Abandoned |
Array
(
[id] => 5277982
[patent_doc_number] => 20090130114
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-21
[patent_title] => 'WISE BINDING AGENTS AND EPITOPES'
[patent_app_type] => utility
[patent_app_number] => 12/275850
[patent_app_country] => US
[patent_app_date] => 2008-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 40
[patent_no_of_words] => 28218
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20090130114.pdf
[firstpage_image] =>[orig_patent_app_number] => 12275850
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/275850 | Wise binding agents and epitopes | Nov 20, 2008 | Issued |
Array
(
[id] => 5575938
[patent_doc_number] => 20090143300
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-04
[patent_title] => 'Treatment of sepsis and septic shock using ghrelin and growth hormone'
[patent_app_type] => utility
[patent_app_number] => 12/291908
[patent_app_country] => US
[patent_app_date] => 2008-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 5412
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20090143300.pdf
[firstpage_image] =>[orig_patent_app_number] => 12291908
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/291908 | Treatment of sepsis and septic shock using ghrelin and growth hormone | Nov 13, 2008 | Issued |
Array
(
[id] => 6596470
[patent_doc_number] => 20100292131
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-18
[patent_title] => 'BIOMARKERS AND METHODS FOR DIAGNOSING, PREDICTING AND/OR PROGNOSING SEPSIS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/742647
[patent_app_country] => US
[patent_app_date] => 2008-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 15883
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0292/20100292131.pdf
[firstpage_image] =>[orig_patent_app_number] => 12742647
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/742647 | BIOMARKERS AND METHODS FOR DIAGNOSING, PREDICTING AND/OR PROGNOSING SEPSIS AND USES THEREOF | Nov 11, 2008 | Abandoned |
Array
(
[id] => 8398185
[patent_doc_number] => 08268566
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-09-18
[patent_title] => 'Enhanced FC receptor-mediated tumor necrosis factor superfamily MRNA expression in peripheral blood leukocytes in patients with rheumatoid arthritis'
[patent_app_type] => utility
[patent_app_number] => 12/743220
[patent_app_country] => US
[patent_app_date] => 2008-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6044
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 130
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12743220
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/743220 | Enhanced FC receptor-mediated tumor necrosis factor superfamily MRNA expression in peripheral blood leukocytes in patients with rheumatoid arthritis | Nov 10, 2008 | Issued |
Array
(
[id] => 7656411
[patent_doc_number] => 20110305680
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-15
[patent_title] => 'Composition Containing Osteopontin for Differentiating Natural Killer Cell as an Active Ingredient and a Method of Differentiation Using Thereof'
[patent_app_type] => utility
[patent_app_number] => 12/995020
[patent_app_country] => US
[patent_app_date] => 2008-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 6400
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0305/20110305680.pdf
[firstpage_image] =>[orig_patent_app_number] => 12995020
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/995020 | Composition Containing Osteopontin for Differentiating Natural Killer Cell as an Active Ingredient and a Method of Differentiation Using Thereof | Nov 9, 2008 | Abandoned |
Array
(
[id] => 6236199
[patent_doc_number] => 20100267612
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-21
[patent_title] => 'SUSTAINED RELEASE COMPOSITION CONTAINING SDF-1'
[patent_app_type] => utility
[patent_app_number] => 12/741694
[patent_app_country] => US
[patent_app_date] => 2008-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 9994
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0267/20100267612.pdf
[firstpage_image] =>[orig_patent_app_number] => 12741694
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/741694 | Sustained release composition containing SDF-1 | Nov 5, 2008 | Issued |
Array
(
[id] => 6494985
[patent_doc_number] => 20100286042
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-11
[patent_title] => 'Medicinal Composition Containing Highly Functionalized Chimeric Protein'
[patent_app_type] => utility
[patent_app_number] => 12/682568
[patent_app_country] => US
[patent_app_date] => 2008-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 13045
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0286/20100286042.pdf
[firstpage_image] =>[orig_patent_app_number] => 12682568
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/682568 | Medicinal Composition Containing Highly Functionalized Chimeric Protein | Oct 9, 2008 | Abandoned |
Array
(
[id] => 5526748
[patent_doc_number] => 20090196825
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-06
[patent_title] => 'CD38 AND OBESITY'
[patent_app_type] => utility
[patent_app_number] => 12/244546
[patent_app_country] => US
[patent_app_date] => 2008-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 9339
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0196/20090196825.pdf
[firstpage_image] =>[orig_patent_app_number] => 12244546
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/244546 | CD38 and obesity | Oct 1, 2008 | Issued |
Array
(
[id] => 6195468
[patent_doc_number] => 20110027222
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-03
[patent_title] => 'Vaccine for the Treatment of Osteoarthritis'
[patent_app_type] => utility
[patent_app_number] => 12/677899
[patent_app_country] => US
[patent_app_date] => 2008-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 10765
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0027/20110027222.pdf
[firstpage_image] =>[orig_patent_app_number] => 12677899
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/677899 | Vaccine for the Treatment of Osteoarthritis | Sep 23, 2008 | Abandoned |
Array
(
[id] => 8675474
[patent_doc_number] => 08383587
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-02-26
[patent_title] => 'Prevention of allergy at weaning'
[patent_app_type] => utility
[patent_app_number] => 12/680083
[patent_app_country] => US
[patent_app_date] => 2008-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3595
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12680083
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/680083 | Prevention of allergy at weaning | Sep 18, 2008 | Issued |
Array
(
[id] => 5441353
[patent_doc_number] => 20090092992
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-09
[patent_title] => 'Novel human dickkopf-related protein and nucleic molecules and uses therefor'
[patent_app_type] => utility
[patent_app_number] => 12/284121
[patent_app_country] => US
[patent_app_date] => 2008-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 55517
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20090092992.pdf
[firstpage_image] =>[orig_patent_app_number] => 12284121
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/284121 | Novel human dickkopf-related protein and nucleic molecules and uses therefor | Sep 16, 2008 | Abandoned |
Array
(
[id] => 5434983
[patent_doc_number] => 20090169569
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-02
[patent_title] => 'APO-2L receptor agonist and CPT-11 synergism'
[patent_app_type] => utility
[patent_app_number] => 12/283526
[patent_app_country] => US
[patent_app_date] => 2008-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 28953
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0169/20090169569.pdf
[firstpage_image] =>[orig_patent_app_number] => 12283526
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/283526 | APO-2L receptor agonist and CPT-11 synergism | Sep 11, 2008 | Abandoned |
Array
(
[id] => 6601652
[patent_doc_number] => 20100322948
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-23
[patent_title] => 'Bone morphogenetic protein (BMP)-binding domains of proteins of the repulsive guidance molecule (RGM) protein family and functional fragments thereof, and use of same'
[patent_app_type] => utility
[patent_app_number] => 12/677054
[patent_app_country] => US
[patent_app_date] => 2008-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 35168
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0322/20100322948.pdf
[firstpage_image] =>[orig_patent_app_number] => 12677054
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/677054 | Bone morphogenetic protein (BMP)-binding domains of proteins of the repulsive guidance molecule (RGM) protein family and functional fragments thereof, and use of same | Sep 7, 2008 | Abandoned |